Invention Grant
- Patent Title: Thiopyrimidinecarboxamides as CXCR1/2 modulators
- Patent Title (中): 硫嘧啶甲酰胺作为CXCR1 / 2调节剂
-
Application No.: US13957665Application Date: 2013-08-02
-
Publication No.: US08969365B2Publication Date: 2015-03-03
- Inventor: Dean Y. Maeda , John A. Zebala , Aaron D. Schuler
- Applicant: Syntrix Biosystems, Inc.
- Applicant Address: US WA Auburn
- Assignee: Syntrix Biosystems, Inc.
- Current Assignee: Syntrix Biosystems, Inc.
- Current Assignee Address: US WA Auburn
- Agency: Baker & Hostetler LLP
- Main IPC: A01N43/54
- IPC: A01N43/54 ; A61K31/505 ; C07F5/02 ; A61K31/69 ; A61K45/06
Abstract:
There is disclosed a pyrimidinecarboxamide compound useful as a pharmaceutical agent, synthetic processes, and pharmaceutical compositions which include the pyrimidinecarboxamide compound. More specifically, there is disclosed a CXCR1/2 inhibitor useful for treating a variety of inflammatory and neoplastic disorders.
Public/Granted literature
- US20150038461A1 THIOPYRIMIDINECARBOXAMIDES AS CXCR1/2 MODULATORS Public/Granted day:2015-02-05
Information query
IPC分类:
